In November 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the weightlifter Sanjita Chanu after her A and B samples tested positive for the prohibited substance Drostanolone.
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substance and argued that she was tested before without issues and while she checked the food and supplements she ingested.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's samples and accordingly that she committed an anti-doping rule violation.
The Panel deems that the Athlete failed to demonstrate with corroborating evidence that the violation was not intentional, nor how the substance had entered her system. The Panel concludes that the Athlete had intentionally used the substance to enhance sport performance.
Therefore the Panel decides on 31 March 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 November 2022.
